慶應義塾

総説・解説等

中原 仁

1~16件(全16件)

Pharmacokinetic-guided Management of Foslevodopa/Foscarbidopa infusion in PINK1-related Parkinson's disease with neuropsychiatric vulnerability

著者名
Okusa S., Shimazu Y., Sakai R., Akiyoshi T., Nukariya T., Nihei Y., Nakahara J., Ohtani H., Seki M.
掲載誌名
誌名Clinical Parkinsonism and Related Disorders (出版年(月日)2026年)

Plasma 3-O-Methyldopa Concentration Monitoring for Treatment Optimization in Foslevodopa/Foscarbidopa Infusion: Implications for Corrected Levodopa Availability: A Case Report

著者名
Okusa S., Okada K., Nihei Y., Sakai R., Akiyoshi T., Nukariya T., Nakahara J., Ohtani H., Seki M.
掲載誌名
誌名Movement Disorders Clinical Practice (出版年(月日)2026年)

Reply: Intention-to-treat analysis, MOH remission, and mechanistic insights: Reframing the 12-month CGRP mAb experience

著者名
Imai S., Ihara K., Takahashi N., Ohtani S., Watanabe N., Iba C., Ishizuchi K., Takemura R., Nakahara J., Hori S., Takizawa T.
掲載誌名
誌名Journal of the Neurological Sciences (出版年(月日)2026年07月)
ISSN
0022510X

Multiple Genetic Analysis Unravels Pseudoexon in ATP7B in a Patient with Clinically Diagnosed Wilson Disease

著者名
Tezuka T., Miya F., Okusa S., Funayama M., Hattori N., Kosaki K., Nakahara J., Seki M.
掲載誌名
誌名Movement Disorders Clinical Practice 巻13(号4) 開始ページ1092 - 終了ページ1095 (出版年(月日)2025年)

Reply: Pathophysiological, methodological, and statistical considerations in CGRP monoclonal antibody therapy: A comment on Imai et al

著者名
Imai S., Ihara K., Takahashi N., Ohtani S., Watanabe N., Iba C., Ishizuchi K., Takemura R., Nakahara J., Hori S., Takizawa T.
掲載誌名
誌名Journal of the Neurological Sciences (出版年(月日)2026年04月)
ISSN
0022510X

A Cautionary Note on the Indication for Deep Brain Stimulation in Parkinsonism Patients With SLC9A6 Gene Mutations

著者名
Okusa S., Tezuka T., Kosugi K., Yamamoto Y., Takahata K., Higuchi M., Akiyama T., Kobayashi M., Toda M., Ito D., Nakahara J., Seki M.
掲載誌名
誌名Journal of Movement Disorders 巻18(号3) 開始ページ268 - 終了ページ270 (出版年(月日)2025年07月)
ISSN
2005940X

Progressive Ataxia and Palatal Tremor Showing Characteristic Tau Depositions in [18F]PM-PBB3 PET

著者名
Tezuka T., Takahata K., Tagai K., Ueda R., Ito D., Takeda H., Takahashi S., Nakahara J., Higuchi M., Seki M.
掲載誌名
誌名Movement Disorders 出版社Movement Disorders 巻37(号6) 開始ページ1317 - 終了ページ1319 (出版年(月日)2022年)
ISSN
08853185

A case of progressive supranuclear palsy with predominant cerebellar ataxia diagnosed by [18F]PM-PBB3 tau PET

著者名
Ishizuchi K., Takizawa T., Tezuka T., Takahata K., Seki M., Tabuchi H., Ueda R., Kubota M., Mimura M., Nakahara J., Ito D.
掲載誌名
誌名Journal of the Neurological Sciences 出版社Journal of the Neurological Sciences (出版年(月日)2021年06月)
ISSN
0022510X

Levodopa Pharmacokinetics in Switching From Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson’s Disease: A Case Report

著者名
Nukariya T., Tezuka T., Okusa S., Okochi R., Sakai Y., Nihei Y., Nakahara J., Seki M.
掲載誌名
誌名Journal of Movement Disorders 巻18(号2) 開始ページ179 - 終了ページ181 (出版年(月日)2025年04月)
ISSN
2005940X

Correction to: Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis (BMC Neurology, (2025), 25, 1, (1), 10.1186/s12883-024-04009-z)

著者名
Tokuyasu D., Imai S., Chen S.P., Ihara K., Watanabe N., Izawa Y., Nakahara J., Hori S., Takizawa T.
掲載誌名
誌名BMC Neurology 巻25(号1) (出版年(月日)2025年12月)

Potential Psychosis Induced by a Sustained High Plasma Levodopa Concentration Due to Continuous Subcutaneous Foslevodopa/ Foscarbidopa Infusion in a Patient With Parkinson’s Disease: A Case Report

著者名
Tezuka T., Nukariya T., Kizuka Y., Okusa S., Okochi R., Sakai Y., Nihei Y., Nakahara J., Seki M.
掲載誌名
誌名Journal of Movement Disorders 巻17(号4) 開始ページ453 - 終了ページ455 (出版年(月日)2024年10月)
ISSN
2005940X

Correction to: Network Meta-analysis of Ravulizumab and Alternative Interventions for the Treatment of Neuromyelitis Optica Spectrum Disorder (Neurology and Therapy, (2024), 13, 3, (535-549), 10.1007/s40120-024-00597-7)

著者名
Clardy S.L., Pittock S.J., Aktas O., Nakahara J., Isobe N., Centonze D., Fam S., Kielhorn A., Yu J.C., Jansen J., Zhang I.
掲載誌名
誌名Neurology and Therapy 出版社Neurology and Therapy 巻13(号4) 開始ページ1313 - 終了ページ1314 (出版年(月日)2024年)
ISSN
21938253

Potential benefits and possible risks of CGRP-targeted multitherapy in migraine

著者名
Ihara K., Takizawa T., Watanabe N., Nakahara J., Martelletti P.
掲載誌名
誌名Expert Opinion on Drug Metabolism and Toxicology 出版社Expert Opinion on Drug Metabolism and Toxicology 巻20(号1-2) 開始ページ1 - 終了ページ4 (出版年(月日)2024年)
ISSN
17425255

Response to letter: “Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule” by Suzuki et al.

著者名
Ihara K., Ohtani S., Watanabe N., Takahashi N., Hori S., Nakahara J., Takizawa T.
掲載誌名
誌名Journal of the Neurological Sciences 出版社Journal of the Neurological Sciences (出版年(月日)2023年12月)
ISSN
0022510X

Flare of myasthenia gravis induced by COVID-19 vaccines

著者名
Ishizuchi K., Takizawa T., Sekiguchi K., Motegi H., Oyama M., Nakahara J., Suzuki S.
掲載誌名
誌名Journal of the Neurological Sciences 出版社Journal of the Neurological Sciences (出版年(月日)2022年05月)
ISSN
0022510X

Time to revisit B cells in multiple sclerosis

著者名
Nakahara J.
掲載誌名
誌名Clinical and Experimental Neuroimmunology 出版社Clinical and Experimental Neuroimmunology 巻12(号4) (出版年(月日)2021年11月)